| |
|
|
|
|
|
|
|||
|
Blood, 21 May 2009, Vol. 113, No. 21, pp. 5202-5205. Prepublished online as a Blood First Edition Paper on March 26, 2009; DOI 10.1182/blood-2008-09-181255.
Submitted September 30, 2008
Laboratory of Immunology, National Institute on Aging-Intramural Research Program, National Institutes of Health, Baltimore, MD, United States * Corresponding author; email: taubd{at}grc.nia.nih.gov.
Ghrelin (Grln) is a peptide hormone that is predominantly produced in the stomach and stimulates appetite and induces Growth Hormone (GH) release. We have previously reported that ghrelin is also expressed in T cells and exerts pro-thymic and anti-inflammatory effects. However, the biological relevance of T-cell derived ghrelin remains to be determined. Here, we report that acylated-bioactive ghrelin is expressed in human T cells and preferentially segregates within the lipid raft domains upon TCR ligation. The RNA interference (RNAi) mediated down regulation of ghrelin in primary human T cells activates IkB, increases Th1 cytokines and IL-17 secretion. Ghrelin expression declines with increasing age in spleen and T cells and exogenous ghrelin administration in old mice reduces pro-inflammatory cytokines. These findings demonstrate that ghrelin functions in an autocrine and paracrine capacity to regulate pro-inflammatory cytokine expression in human and murine T cells and may contribute in regulating 'inflamm-aging'.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||